[1]
“Biologics and small molecules treatment for moderate-to-severe atopic dermatitis patients with comorbid conditions and special populations: an Italian perspective”, Dermatol Reports, vol. 16, no. 2, Sep. 2023, doi: 10.4081/dr.2023.9839.